Brief report · 29 Dec 2025
Conference abstractPublished 17 Jun 2019
Diarylacetylenes as inhibitors of Methionine S Adenosyltransferase-2 for hepatocellular and colorectal cancer treatment
University of Kentucky, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide. CRC is initiated by mutations of the tumor suppressor gene, adenomatous polyposis coli (APC), or β-catenin gene. These mutations stabilize β-catenin and constitutively activate Wnt/β -catenin target genes, such as c-Myc and cyclin D1, ultimately leading to cancer. We developed a family of fluorinated diarylacetylene agents, called FIDAS agents, that inhibit the proliferation of CRC cells in vitro at nanomolar levels and in vivo at a dosage of 20 mg/kg. Using a biotinylated FIDAS analogue, we identified the catalytic subunit (MAT2A) of MAT2 as the direct and exclusive binding target of these diarylacetylene-based FIDAS agents. Structure-activity relationships defined the nature of aryl and heteroaryl rings as well as the substituents on these rings associated with potency as MAT2 inhibitors. MAT2 is up-regulated in many cancers, including liver cancers and colorectal cancers (CRC) and is a potentially important drug target. FIDAS agents inhibited MAT2 selectively without affecting MAT1 that supplies SAM for most cellular needs. Validation of MAT2 as a cancer target relied on the observation that shRNAs also inhibited CRC cell growth. A diarylacetylenebased FIDAS agent delivered orally repressed CRC and hepatocellular cancer xenografts in athymic nude mice. These findings suggest that diarylacetylene-based FIDAS analogs function as epigenetic regulators by targeting MAT2 and represent a family of novel and potentially useful agents for cancer treatment.
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Chemical Sciences Journal.
Brief report · 29 Dec 2025
Cheminformatics: Data-Driven Chemistry's Transformative Impact
Opinion · 29 Dec 2025
Polymers: Engineering Biomedicine's Future Through Innovation
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemical Sciences Journal
- SubjectChemistry
- BylineArticles whose byline prints “Liliia M Kril”
